{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T02:12:00Z","timestamp":1778724720689,"version":"3.51.4"},"reference-count":140,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.cbi.2026.112084","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T13:10:50Z","timestamp":1776172250000},"page":"112084","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Solute carrier transporters in tumor metabolism and tumor immunity"],"prefix":"10.1016","volume":"433","author":[{"given":"Miaobo","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heling","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinlong","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiajing","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.cbi.2026.112084_bib1","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1111\/febs.15531","article-title":"A guide to plasma membrane solute carrier proteins","volume":"288","author":"Pizzagalli","year":"2021","journal-title":"FEBS J."},{"issue":"Suppl 1","key":"10.1016\/j.cbi.2026.112084_bib2","first-page":"S397","article-title":"The concise guide to pharmacology 2019\/20: transporters","volume":"176","author":"Alexander","year":"2019","journal-title":"Br. J. Pharmacol."},{"issue":"2\u20133","key":"10.1016\/j.cbi.2026.112084_bib3","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.mam.2012.12.007","article-title":"Solute carriers (SLCs) in cancer","volume":"34","author":"El-Gebali","year":"2013","journal-title":"Mol. Aspect. Med."},{"issue":"4","key":"10.1016\/j.cbi.2026.112084_bib4","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.cell.2025.01.015","article-title":"Solute carriers: the gatekeepers of metabolism","volume":"188","author":"Khan","year":"2025","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.cbi.2026.112084_bib5","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nrd4626","article-title":"SLC transporters as therapeutic targets: emerging opportunities","volume":"14","author":"Lin","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.cbi.2026.112084_bib6","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s40364-024-00645-2","article-title":"The solute carrier transporters (SLCs) family in nutrient metabolism and ferroptosis","volume":"12","author":"Sun","year":"2024","journal-title":"Biomark. Res."},{"issue":"7","key":"10.1016\/j.cbi.2026.112084_bib7","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/j.drudis.2021.03.004","article-title":"Solute carriers as potential oncodrivers or suppressors: their key functions in malignant tumor formation","volume":"26","author":"Rashid","year":"2021","journal-title":"Drug Discov. Today"},{"issue":"5","key":"10.1016\/j.cbi.2026.112084_bib8","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.cbi.2026.112084_bib9","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1038\/s41418-022-01022-y","article-title":"Targeting mitochondrial metabolism for precision medicine in cancer","volume":"29","author":"Sainero-Alcolado","year":"2022","journal-title":"Cell Death Differ."},{"issue":"4","key":"10.1016\/j.cbi.2026.112084_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2025.167731","article-title":"A detailed review on the role of miRNAs in mitochondrial-nuclear cross talk during cancer progression","volume":"1871","author":"Kandettu","year":"2025","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"issue":"19","key":"10.1016\/j.cbi.2026.112084_bib11","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1038\/s41388-019-0688-7","article-title":"Lactate modulates CD4+ T-cell polarization and induces an immunosuppressive environment, which sustains prostate carcinoma progression via TLR8\/miR21 axis","volume":"38","author":"Comito","year":"2019","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.cbi.2026.112084_bib12","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1007\/s00439-001-0615-0","article-title":"The HUGO Gene Nomenclature Committee (HGNC)","volume":"109","author":"Povey","year":"2001","journal-title":"Hum. Genet."},{"issue":"3","key":"10.1016\/j.cbi.2026.112084_bib13","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.tips.2016.11.008","article-title":"Classification systems of secondary active transporters","volume":"38","author":"Perland","year":"2017","journal-title":"Trends Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.cbi.2026.112084_bib14","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1177\/2472555220960401","article-title":"Cryo-EM: the resolution revolution and drug discovery","volume":"26","author":"de Oliveira","year":"2021","journal-title":"SLAS Discov."},{"issue":"D1","key":"10.1016\/j.cbi.2026.112084_bib15","doi-asserted-by":"crossref","first-page":"D506","DOI":"10.1093\/nar\/gky1049","article-title":"UniProt: a worldwide hub of protein knowledge","volume":"47","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.cbi.2026.112084_bib16","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1146\/annurev-biophys-083012-130429","article-title":"Common folds and transport mechanisms of secondary active transporters","volume":"42","author":"Shi","year":"2013","journal-title":"Annu. Rev. Biophys."},{"issue":"9","key":"10.1016\/j.cbi.2026.112084_bib17","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.tibs.2023.05.011","article-title":"Targeting SLC transporters: small molecules as modulators and therapeutic opportunities","volume":"48","author":"Schlessinger","year":"2023","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.cbi.2026.112084_bib18","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1146\/annurev-biophys-060414-033901","article-title":"Structural biology of the major facilitator superfamily transporters","volume":"44","author":"Yan","year":"2015","journal-title":"Annu. Rev. Biophys."},{"issue":"30","key":"10.1016\/j.cbi.2026.112084_bib19","doi-asserted-by":"crossref","first-page":"10338","DOI":"10.1073\/pnas.0804659105","article-title":"Mechanism for alternating access in neurotransmitter transporters","volume":"105","author":"Forrest","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"issue":"5","key":"10.1016\/j.cbi.2026.112084_bib20","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1113\/jphysiol.2013.259051","article-title":"How LeuT shapes our understanding of the mechanisms of sodium-coupled neurotransmitter transporters","volume":"592","author":"Penmatsa","year":"2014","journal-title":"J. Physiol."},{"issue":"16","key":"10.1016\/j.cbi.2026.112084_bib21","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.15252\/embj.201387557","article-title":"Molecular mechanism of ligand recognition by membrane transport protein, Mhp1","volume":"33","author":"Simmons","year":"2014","journal-title":"EMBO J."},{"issue":"3","key":"10.1016\/j.cbi.2026.112084_bib22","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nsmb.3164","article-title":"Crystal structures reveal the molecular basis of ion translocation in sodium\/proton antiporters","volume":"23","author":"Coincon","year":"2016","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.cbi.2026.112084_bib23","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1146\/annurev-biochem-060815-014520","article-title":"Shared molecular mechanisms of membrane transporters","volume":"85","author":"Drew","year":"2016","journal-title":"Annu. Rev. Biochem."},{"issue":"1","key":"10.1016\/j.cbi.2026.112084_bib24","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.tips.2020.11.005","article-title":"Targeting solute carrier transporters through functional mapping","volume":"42","author":"Colas","year":"2021","journal-title":"Trends Pharmacol. Sci."},{"issue":"4","key":"10.1016\/j.cbi.2026.112084_bib25","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1534\/genetics.117.300327","article-title":"Substrate specificity of the FurE transporter is determined by cytoplasmic terminal domain interactions","volume":"207","author":"Papadaki","year":"2017","journal-title":"Genetics"},{"key":"10.1016\/j.cbi.2026.112084_bib26","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.pharmthera.2018.06.013","article-title":"Post-translational modifications of transporters","volume":"192","author":"Czuba","year":"2018","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.cbi.2026.112084_bib27","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40170-025-00376-4","article-title":"Serine starvation suppresses the progression of esophageal cancer by regulating the synthesis of purine nucleotides and NADPH","volume":"13","author":"Jie","year":"2025","journal-title":"Cancer Metabol."},{"issue":"1","key":"10.1016\/j.cbi.2026.112084_bib28","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s40170-024-00360-4","article-title":"CYP19A1 regulates chemoresistance in colorectal cancer through modulation of estrogen biosynthesis and mitochondrial function","volume":"12","author":"Wang","year":"2024","journal-title":"Cancer Metabol."},{"issue":"3","key":"10.1016\/j.cbi.2026.112084_bib29","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.cmet.2020.06.019","article-title":"Mitochondrial metabolism as a target for cancer therapy","volume":"32","author":"Vasan","year":"2020","journal-title":"Cell Metab."},{"issue":"3","key":"10.1016\/j.cbi.2026.112084_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/cells7030021","article-title":"Elucidating the metabolic plasticity of cancer: mitochondrial reprogramming and hybrid metabolic states","volume":"7","author":"Jia","year":"2018","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.cbi.2026.112084_bib31","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/cpt.2627","article-title":"New and emerging research on solute carrier and ATP binding cassette transporters in drug discovery and development: outlook from the international transporter consortium","volume":"112","author":"Giacomini","year":"2022","journal-title":"Clin. Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.cbi.2026.112084_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/biom10040655","article-title":"Diseases caused by mutations in mitochondrial carrier genes SLC25: a review","volume":"10","author":"Palmieri","year":"2020","journal-title":"Biomolecules"},{"issue":"5","key":"10.1016\/j.cbi.2026.112084_bib33","first-page":"1548","article-title":"SLC25A18 has prognostic value in colorectal cancer and represses Warburg effect and cell proliferation via Wnt signaling","volume":"10","author":"Liang","year":"2020","journal-title":"Am. J. Cancer Res."},{"issue":"6","key":"10.1016\/j.cbi.2026.112084_bib34","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1097\/HEP.0000000000000314","article-title":"Hepatic mitochondrial NAD + transporter SLC25A47 activates AMPK\u03b1 mediating lipid metabolism and tumorigenesis","volume":"78","author":"Cheng","year":"2023","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.cbi.2026.112084_bib35","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1038\/s41418-018-0101-z","article-title":"The mitochondrial citrate carrier, SLC25A1, drives stemness and therapy resistance in non-small cell lung cancer","volume":"25","author":"Fernandez","year":"2018","journal-title":"Cell Death Differ."},{"issue":"12","key":"10.1016\/j.cbi.2026.112084_bib36","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1038\/s41419-021-04411-2","article-title":"SLC25A1 promotes tumor growth and survival by reprogramming energy metabolism in colorectal cancer","volume":"12","author":"Yang","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cbi.2026.112084_bib37","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.freeradbiomed.2015.04.032","article-title":"UCP2 inhibition sensitizes breast cancer cells to therapeutic agents by increasing oxidative stress","volume":"86","author":"Pons","year":"2015","journal-title":"Free Radic. Biol. Med."},{"issue":"2","key":"10.1016\/j.cbi.2026.112084_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2019.11.020","article-title":"A variant of SLC1A5 is a mitochondrial glutamine transporter for metabolic reprogramming in cancer cells","volume":"31","author":"Yoo","year":"2020","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.cbi.2026.112084_bib39","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s40170-025-00382-6","article-title":"Unveiling the powerhouse: ASCL1-driven small cell lung cancer is characterized by higher numbers of mitochondria and enhanced oxidative phosphorylation","volume":"13","author":"Solta","year":"2025","journal-title":"Cancer Metabol."},{"issue":"2","key":"10.1016\/j.cbi.2026.112084_bib40","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.218","article-title":"Metabolic reprogramming in cancer: mechanisms and therapeutics","volume":"4","author":"Nong","year":"2023","journal-title":"MedComm"},{"issue":"1","key":"10.1016\/j.cbi.2026.112084_bib41","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40170-025-00373-7","article-title":"GDF15-mediated enhancement of the Warburg effect sustains multiple myeloma growth via TGF\u03b2 signaling pathway","volume":"13","author":"Xue","year":"2025","journal-title":"Cancer Metabol."},{"issue":"1","key":"10.1016\/j.cbi.2026.112084_bib42","doi-asserted-by":"crossref","first-page":"5436","DOI":"10.1038\/s41467-020-19263-1","article-title":"Ketohexokinase-A acts as a nuclear protein kinase that mediates fructose-induced metastasis in breast cancer","volume":"11","author":"Kim","year":"2020","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.cbi.2026.112084_bib43","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.131596","article-title":"GLUT5-mediated fructose utilization drives lung cancer growth by stimulating fatty acid synthesis and AMPK\/mTORC1 signaling","volume":"5","author":"Chen","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.cbi.2026.112084_bib44","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.2147\/CMAR.S195424","article-title":"SLC5A1 promotes growth and proliferation of pancreatic carcinoma via glucose-dependent AMPK\/mTOR signaling","volume":"11","author":"Gao","year":"2019","journal-title":"Cancer Manag. Res."},{"issue":"1","key":"10.1016\/j.cbi.2026.112084_bib45","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13046-018-0673-y","article-title":"Autophagy promotes metastasis and glycolysis by upregulating MCT1 expression and Wnt\/\u03b2-catenin signaling pathway activation in hepatocellular carcinoma cells","volume":"37","author":"Fan","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"12","key":"10.1016\/j.cbi.2026.112084_bib46","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1002\/mc.22707","article-title":"Monocarboxylate transporter 1 is a key player in glioma-endothelial cell crosstalk","volume":"56","author":"Miranda-Gon\u00e7alves","year":"2017","journal-title":"Mol. Carcinog."},{"issue":"7","key":"10.1016\/j.cbi.2026.112084_bib47","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1002\/ijc.29535","article-title":"Targeting SLC1a5-mediated glutamine dependence in non-small cell lung cancer","volume":"137","author":"Hassanein","year":"2015","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.cbi.2026.112084_bib48","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s10528-021-10092-5","article-title":"Circ_0072995 promotes ovarian cancer progression through regulating miR-122-5p\/SLC1A5 Axis","volume":"60","author":"Huang","year":"2022","journal-title":"Biochem. Genet."},{"issue":"3","key":"10.1016\/j.cbi.2026.112084_bib49","doi-asserted-by":"crossref","first-page":"862","DOI":"10.3892\/or.2012.1878","article-title":"c-Myc is crucial for the expression of LAT1 in MIA Paca-2 human pancreatic cancer cells","volume":"28","author":"Hayashi","year":"2012","journal-title":"Oncol. Rep."},{"issue":"1","key":"10.1016\/j.cbi.2026.112084_bib50","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12943-024-02224-3","article-title":"CircTTC13 promotes sorafenib resistance in hepatocellular carcinoma through the inhibition of ferroptosis by targeting the miR-513a-5p\/SLC7A11 axis","volume":"24","author":"Zhang","year":"2025","journal-title":"Mol. Cancer"},{"issue":"36","key":"10.1016\/j.cbi.2026.112084_bib51","doi-asserted-by":"crossref","first-page":"5007","DOI":"10.1038\/s41388-018-0307-z","article-title":"xCT (SLC7A11)-mediated metabolic reprogramming promotes non-small cell lung cancer progression","volume":"37","author":"Ji","year":"2018","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.cbi.2026.112084_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2020.165747","article-title":"MiR-139-5p\/SLC7A11 inhibits the proliferation, invasion and metastasis of pancreatic carcinoma via PI3K\/Akt signaling pathway","volume":"1866","author":"Zhu","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"issue":"1","key":"10.1016\/j.cbi.2026.112084_bib53","doi-asserted-by":"crossref","first-page":"7522","DOI":"10.1038\/s41467-024-51860-2","article-title":"SLC13A3 is a major effector downstream of activated \u03b2-catenin in liver cancer pathogenesis","volume":"15","author":"Zhao","year":"2024","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.cbi.2026.112084_bib54","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/hep.28223","article-title":"Yes-associated protein 1 and transcriptional coactivator with PDZ-binding motif activate the mammalian target of rapamycin complex 1 pathway by regulating amino acid transporters in hepatocellular carcinoma","volume":"63","author":"Park","year":"2016","journal-title":"Hepatology"},{"issue":"17","key":"10.1016\/j.cbi.2026.112084_bib55","doi-asserted-by":"crossref","first-page":"15879","DOI":"10.1007\/s00432-023-05360-3","article-title":"Integrative analysis reveals that SLC38A1 promotes hepatocellular carcinoma development via PI3K\/AKT\/mTOR signaling via glutamine mediated energy metabolism","volume":"149","author":"Feng","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.cbi.2026.112084_bib56","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1042\/BJ20150242","article-title":"Slc5a8, a Na+-coupled high-affinity transporter for short-chain fatty acids, is a conditional tumour suppressor in colon that protects against colitis and colon cancer under low-fibre dietary conditions","volume":"469","author":"Gurav","year":"2015","journal-title":"Biochem. J."},{"issue":"33","key":"10.1016\/j.cbi.2026.112084_bib57","doi-asserted-by":"crossref","first-page":"13890","DOI":"10.1074\/jbc.M117.783860","article-title":"Silencing of solute carrier family 13 member 5 disrupts energy homeostasis and inhibits proliferation of human hepatocarcinoma cells","volume":"292","author":"Li","year":"2017","journal-title":"J. Biol. Chem."},{"issue":"21","key":"10.1016\/j.cbi.2026.112084_bib58","doi-asserted-by":"crossref","first-page":"9620","DOI":"10.7150\/thno.44176","article-title":"LncRNA-SLC16A1-AS1 induces metabolic reprogramming during Bladder Cancer progression as target and co-activator of E2F1","volume":"10","author":"Logotheti","year":"2020","journal-title":"Theranostics"},{"issue":"8","key":"10.1016\/j.cbi.2026.112084_bib59","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1158\/2159-8290.CD-17-1371","article-title":"Adipocyte-derived lipids mediate melanoma progression via FATP proteins","volume":"8","author":"Zhang","year":"2018","journal-title":"Cancer Discov."},{"issue":"1","key":"10.1016\/j.cbi.2026.112084_bib60","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/s13046-024-03114-8","article-title":"SLC14A1 and TGF-\u03b2 signaling: a feedback loop driving EMT and colorectal cancer metachronous liver metastasis","volume":"43","author":"Zhang","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.cbi.2026.112084_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.105764","article-title":"SLC17A9-PTHLH-EMT axis promotes proliferation and invasion of clear renal cell carcinoma","volume":"26","author":"Li","year":"2023","journal-title":"iScience"},{"issue":"4","key":"10.1016\/j.cbi.2026.112084_bib62","first-page":"813","article-title":"LIV-1 enhances the aggressive phenotype through the induction of epithelial to mesenchymal transition in human pancreatic carcinoma cells","volume":"35","author":"Unno","year":"2009","journal-title":"Int. J. Oncol."},{"issue":"1","key":"10.1016\/j.cbi.2026.112084_bib63","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/cac2.12613","article-title":"Effect of neutrophils on tumor immunity and immunotherapy resistance with underlying mechanisms","volume":"45","author":"Yao","year":"2025","journal-title":"Cancer Commun."},{"issue":"4","key":"10.1016\/j.cbi.2026.112084_bib64","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.trecan.2022.12.008","article-title":"T cell exhaustion in malignant gliomas","volume":"9","author":"Watowich","year":"2023","journal-title":"Trends Cancer"},{"issue":"1","key":"10.1016\/j.cbi.2026.112084_bib65","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/imr.12218","article-title":"Macrophage phenotypes in atherosclerosis","volume":"262","author":"Colin","year":"2014","journal-title":"Immunol. Rev."},{"issue":"10","key":"10.1016\/j.cbi.2026.112084_bib66","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41568-022-00491-0","article-title":"Natural killer cells in antitumour adoptive cell immunotherapy","volume":"22","author":"Laskowski","year":"2022","journal-title":"Nat. Rev. Cancer"},{"issue":"16","key":"10.1016\/j.cbi.2026.112084_bib67","doi-asserted-by":"crossref","first-page":"4097","DOI":"10.1158\/0008-5472.CAN-12-0448","article-title":"Caveolin-1 increases aerobic glycolysis in colorectal cancers by stimulating HMGA1-mediated GLUT3 transcription","volume":"72","author":"Ha","year":"2012","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.cbi.2026.112084_bib68","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/ncb1724","article-title":"p53 regulates glucose metabolism through an IKK-NF-kappaB pathway and inhibits cell transformation","volume":"10","author":"Kawauchi","year":"2008","journal-title":"Nat. Cell Biol."},{"issue":"5","key":"10.1016\/j.cbi.2026.112084_bib69","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.arcmed.2012.07.003","article-title":"Effect on the expression of MMP-2, MT-MMP in laryngeal carcinoma Hep-2 cell line by antisense glucose transporter-1","volume":"43","author":"Xu","year":"2012","journal-title":"Arch. Med. Res."},{"issue":"12","key":"10.1016\/j.cbi.2026.112084_bib70","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/s41419-022-05526-w","article-title":"SLC1A5 enhances malignant phenotypes through modulating ferroptosis status and immune microenvironment in glioma","volume":"13","author":"Han","year":"2022","journal-title":"Cell Death Dis."},{"issue":"36","key":"10.1016\/j.cbi.2026.112084_bib71","doi-asserted-by":"crossref","first-page":"31830","DOI":"10.1074\/jbc.M111.229518","article-title":"SLC6A14 (ATB0,+) protein, a highly concentrative and broad specific amino acid transporter, is a novel and effective drug target for treatment of estrogen receptor-positive breast cancer","volume":"286","author":"Karunakaran","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"14","key":"10.1016\/j.cbi.2026.112084_bib72","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13143541","article-title":"Arginine signaling and cancer metabolism","volume":"13","author":"Chen","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.cbi.2026.112084_bib73","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/9008685","article-title":"Characterisation of expression the arginine pathway enzymes in childhood brain tumours to determine susceptibility to therapeutic arginine depletion","volume":"2022","author":"Bishop","year":"2022","journal-title":"BioMed Res. Int."},{"issue":"18","key":"10.1016\/j.cbi.2026.112084_bib74","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25189782","article-title":"Pathophysiology of arginases in cancer and efforts in their pharmacological inhibition","volume":"25","author":"Marz\u0119ta-Assas","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.cbi.2026.112084_bib75","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s12967-025-06086-1","article-title":"Single-cell profiling of SLC family transporters: uncovering the role of SLC7A1 in osteosarcoma","volume":"23","author":"Liao","year":"2025","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.cbi.2026.112084_bib76","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3892\/ol.2024.14772","article-title":"SLC7A5 regulates tryptophan uptake and PD-L1 expression levels via the kynurenine pathway in ovarian cancer","volume":"29","author":"Jiang","year":"2024","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.cbi.2026.112084_bib77","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.636081","article-title":"Tryptophan: a rheostat of cancer immune escape mediated by immunosuppressive enzymes IDO1 and TDO","volume":"12","author":"Kim","year":"2021","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.cbi.2026.112084_bib78","doi-asserted-by":"crossref","first-page":"4677","DOI":"10.1038\/s41467-023-39571-6","article-title":"Targeting of SLC25A22 boosts the immunotherapeutic response in KRAS-mutant colorectal cancer","volume":"14","author":"Zhou","year":"2023","journal-title":"Nat. Commun."},{"issue":"33","key":"10.1016\/j.cbi.2026.112084_bib79","article-title":"Targeting glutamine metabolism transporter SLC25A22 enhances CD8+ T-Cell function and Anti-PD-1 therapy efficacy in cervical squamous cell carcinoma: integrated metabolomics, transcriptomics and T-Cell-Incorporated tumor organoid studies","volume":"12","author":"Ren","year":"2025","journal-title":"Adv. Sci. (Weinh.)"},{"issue":"6","key":"10.1016\/j.cbi.2026.112084_bib80","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.4049\/jimmunol.1502464","article-title":"Suppression of Glut1 and glucose metabolism by decreased Akt\/mTORC1 signaling drives T cell impairment in B cell leukemia","volume":"197","author":"Siska","year":"2016","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.cbi.2026.112084_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2019.08.068","article-title":"Restricting glycolysis preserves T cell effector functions and augments checkpoint therapy","volume":"29","author":"Renner","year":"2019","journal-title":"Cell Rep."},{"issue":"7519","key":"10.1016\/j.cbi.2026.112084_bib82","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nature13490","article-title":"Functional polarization of tumour-associated macrophages by tumour-derived lactic acid","volume":"513","author":"Colegio","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.cbi.2026.112084_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108300","article-title":"Nucleoside transporters and immunosuppressive adenosine signaling in the tumor microenvironment: potential therapeutic opportunities","volume":"240","author":"Kaur","year":"2022","journal-title":"Pharmacol. Ther."},{"issue":"12","key":"10.1016\/j.cbi.2026.112084_bib84","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1002\/iub.2905","article-title":"Extracellular adenosine oppositely regulates the purinome machinery in glioblastoma and mesenchymal stem cells","volume":"76","author":"Pietrobono","year":"2024","journal-title":"IUBMB Life"},{"issue":"12","key":"10.1016\/j.cbi.2026.112084_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2024.10.010","article-title":"Itaconate transporter SLC13A3 impairs tumor immunity via endowing ferroptosis resistance","volume":"42","author":"Lin","year":"2024","journal-title":"Cancer Cell"},{"issue":"762","key":"10.1016\/j.cbi.2026.112084_bib86","doi-asserted-by":"crossref","first-page":"eadk7399","DOI":"10.1126\/scitranslmed.adk7399","article-title":"Activation and antitumor immunity of CD8+ T cells are supported by the glucose transporter GLUT10 and disrupted by lactic acid","volume":"16","author":"Liu","year":"2024","journal-title":"Sci. Transl. Med."},{"issue":"12","key":"10.1016\/j.cbi.2026.112084_bib87","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1084\/jem.20182044","article-title":"Creatine uptake regulates CD8 T cell antitumor immunity","volume":"216","author":"Di","year":"2019","journal-title":"J. Exp. Med."},{"issue":"41","key":"10.1016\/j.cbi.2026.112084_bib88","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.1038\/s41388-025-03543-5","article-title":"Slc7a5 promotes T cell anti-tumor immunity through sustaining cytotoxic T lymphocyte effector function","volume":"44","author":"Lu","year":"2025","journal-title":"Oncogene"},{"issue":"9","key":"10.1016\/j.cbi.2026.112084_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2023.07.001","article-title":"Tumor aerobic glycolysis confers immune evasion through modulating sensitivity to T cell-mediated bystander killing via TNF-\u03b1","volume":"35","author":"Wu","year":"2023","journal-title":"Cell Metab."},{"issue":"12","key":"10.1016\/j.cbi.2026.112084_bib90","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1158\/0008-5472.CAN-24-3180","article-title":"SLC3A2-Mediated lysine uptake by cancer cells restricts T-cell activity in hepatocellular carcinoma","volume":"85","author":"Chang","year":"2025","journal-title":"Cancer Res."},{"issue":"9","key":"10.1016\/j.cbi.2026.112084_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2024.03.011","article-title":"Cancer SLC6A6-mediated taurine uptake transactivates immune checkpoint genes and induces exhaustion in CD8+ T cells","volume":"187","author":"Cao","year":"2024","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.cbi.2026.112084_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2018.02.005","article-title":"Tumor-repopulating cells induce PD-1 expression in CD8+ T cells by transferring kynurenine and AhR activation","volume":"33","author":"Liu","year":"2018","journal-title":"Cancer Cell"},{"issue":"7","key":"10.1016\/j.cbi.2026.112084_bib93","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1111\/cas.14069","article-title":"Regulatory T (Treg) cells in cancer: can Treg cells be a new therapeutic target?","volume":"110","author":"Ohue","year":"2019","journal-title":"Cancer Sci."},{"issue":"7851","key":"10.1016\/j.cbi.2026.112084_bib94","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/s41586-020-03045-2","article-title":"Metabolic support of tumour-infiltrating regulatory T cells by lactic acid","volume":"591","author":"Watson","year":"2021","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.cbi.2026.112084_bib95","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1038\/s41590-024-01999-3","article-title":"Dysfunction of exhausted T cells is enforced by MCT11-mediated lactate metabolism","volume":"25","author":"Peralta","year":"2024","journal-title":"Nat. Immunol."},{"issue":"7824","key":"10.1016\/j.cbi.2026.112084_bib96","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/s41586-020-2682-1","article-title":"Cancer SLC43A2 alters T cell methionine metabolism and histone methylation","volume":"585","author":"Bian","year":"2020","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.cbi.2026.112084_bib97","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1182\/bloodadvances.2022008272","article-title":"Engineering amino acid uptake or catabolism promotes CAR T-cell adaption to the tumor environment","volume":"7","author":"Panetti","year":"2023","journal-title":"Blood Adv."},{"issue":"1","key":"10.1016\/j.cbi.2026.112084_bib98","doi-asserted-by":"crossref","first-page":"9690","DOI":"10.1038\/s41467-025-64730-2","article-title":"Targeting cancer glutamine dependency with a first-in-class inhibitor of the mitochondrial glutamine transporter SLC1A5_var","volume":"16","author":"Sung","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cbi.2026.112084_bib99","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1251643","article-title":"Targeting glutamine metabolic reprogramming of SLC7A5 enhances the efficacy of anti-PD-1 in triple-negative breast cancer","volume":"14","author":"Huang","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cbi.2026.112084_bib100","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216824","article-title":"Targeting tumor-intrinsic SLC16A3 to enhance anti-PD-1 efficacy via tumor immune microenvironment reprogramming","volume":"589","author":"Yu","year":"2024","journal-title":"Cancer Lett."},{"issue":"7755","key":"10.1016\/j.cbi.2026.112084_bib101","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-019-1170-y","article-title":"CD8+ T cells regulate tumour ferroptosis during cancer immunotherapy","volume":"569","author":"Wang","year":"2019","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.cbi.2026.112084_bib102","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1158\/1078-0432.CCR-07-4913","article-title":"Interaction of imatinib with human organic ion carriers","volume":"14","author":"Hu","year":"2008","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.cbi.2026.112084_bib103","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1124\/jpet.106.104364","article-title":"Interaction of methotrexate with organic-anion transporting polypeptide 1A2 and its genetic variants","volume":"318","author":"Badagnani","year":"2006","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"5","key":"10.1016\/j.cbi.2026.112084_bib104","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s00280-015-2723-x","article-title":"Organic cation transporter OCT6 mediates cisplatin uptake and resistance to cisplatin in lung cancer","volume":"75","author":"Kunii","year":"2015","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"7","key":"10.1016\/j.cbi.2026.112084_bib105","first-page":"895","article-title":"Expression of human equilibrative nucleoside transporter 1 (hENT1) and its correlation with gemcitabine uptake and cytotoxicity in mantle cell lymphoma","volume":"91","author":"Marc\u00e9","year":"2006","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.cbi.2026.112084_bib106","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/bjs.10482","article-title":"Immunohistochemical hENT1 expression as a prognostic biomarker in patients with resected pancreatic ductal adenocarcinoma undergoing adjuvant gemcitabine-based chemotherapy","volume":"104","author":"Bird","year":"2017","journal-title":"Br. J. Surg."},{"issue":"6","key":"10.1016\/j.cbi.2026.112084_bib107","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.biopha.2011.04.031","article-title":"Expression of organic anion-transporting polypeptides 1B1 and 1B3 in ovarian cancer cells: relevance for paclitaxel transport","volume":"65","author":"Svoboda","year":"2011","journal-title":"Biomed. Pharmacother."},{"issue":"7","key":"10.1016\/j.cbi.2026.112084_bib108","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1053\/gast.2001.24804","article-title":"LST-2, a human liver-specific organic anion transporter, determines methotrexate sensitivity in gastrointestinal cancers","volume":"120","author":"Abe","year":"2001","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.cbi.2026.112084_bib109","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-72099-z","article-title":"A membrane transporter determines the spectrum of activity of a potent platinum-acridine hybrid anticancer agent","volume":"10","author":"Yao","year":"2020","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.cbi.2026.112084_bib110","first-page":"4021","article-title":"Targeting the multidrug and toxin extrusion 1 gene (SLC47A1) sensitizes glioma stem cells to temozolomide","volume":"13","author":"Batara","year":"2023","journal-title":"Am. J. Cancer Res."},{"issue":"12","key":"10.1016\/j.cbi.2026.112084_bib111","first-page":"1627","article-title":"Nintedanib enhances tumor cell radiosensitivity by promoting ferroptosis and modulating the ATF4\/SLC7A11\/GSH axis","volume":"22","author":"Li","year":"2025","journal-title":"Cancer Biol. Med."},{"issue":"12","key":"10.1016\/j.cbi.2026.112084_bib112","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1158\/2159-8290.CD-19-0338","article-title":"Radiotherapy and immunotherapy promote tumoral lipid oxidation and ferroptosis via synergistic repression of SLC7A11","volume":"9","author":"Lang","year":"2019","journal-title":"Cancer Discov."},{"issue":"10","key":"10.1016\/j.cbi.2026.112084_bib113","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1111\/jcmm.17303","article-title":"Effect of Glut-1 and HIF-1\u03b1 double knockout by CRISPR\/CAS9 on radiosensitivity in laryngeal carcinoma via the PI3K\/Akt\/mTOR pathway","volume":"26","author":"Bao","year":"2022","journal-title":"J. Cell Mol. Med."},{"issue":"1","key":"10.1016\/j.cbi.2026.112084_bib114","doi-asserted-by":"crossref","first-page":"6714","DOI":"10.1038\/s41467-022-34284-8","article-title":"Structural basis of organic cation transporter-3 inhibition","volume":"13","author":"Khanppnavar","year":"2022","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.cbi.2026.112084_bib115","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/nchembio.1590","article-title":"The solute carrier SLC35F2 enables YM155-mediated DNA damage toxicity","volume":"10","author":"Winter","year":"2014","journal-title":"Nat. Chem. Biol."},{"issue":"12","key":"10.1016\/j.cbi.2026.112084_bib116","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1002\/ijc.31274","article-title":"Inhibition of SLC1A5 sensitizes colorectal cancer to cetuximab","volume":"142","author":"Ma","year":"2018","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.cbi.2026.112084_bib117","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s40170-023-00306-2","article-title":"Safety, tolerability, and effectiveness of the sodium-glucose cotransporter 2 inhibitor (SGLT2i) dapagliflozin in combination with standard chemotherapy for patients with advanced, inoperable pancreatic adenocarcinoma: a phase 1b observational study","volume":"11","author":"Park","year":"2023","journal-title":"Cancer Metabol."},{"issue":"1","key":"10.1016\/j.cbi.2026.112084_bib118","article-title":"Comparing mechanism-based and machine learning models for predicting the effects of glucose accessibility on tumor cell proliferation","volume":"13","author":"Yang","year":"2023","journal-title":"Sci. Rep."},{"issue":"94","key":"10.1016\/j.cbi.2026.112084_bib119","doi-asserted-by":"crossref","first-page":"94ra70","DOI":"10.1126\/scitranslmed.3002394","article-title":"Targeting GLUT1 and the Warburg effect in renal cell carcinoma by chemical synthetic lethality","volume":"3","author":"Chan","year":"2011","journal-title":"Sci. Transl. Med."},{"issue":"8","key":"10.1016\/j.cbi.2026.112084_bib120","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1158\/1535-7163.MCT-12-0131","article-title":"A small-molecule inhibitor of glucose transporter 1 downregulates glycolysis, induces cell-cycle arrest, and inhibits cancer cell growth in vitro and in vivo","volume":"11","author":"Liu","year":"2012","journal-title":"Mol. Cancer Therapeut."},{"issue":"1","key":"10.1016\/j.cbi.2026.112084_bib121","doi-asserted-by":"crossref","first-page":"4205","DOI":"10.1038\/s41467-020-18020-8","article-title":"GLUT1 inhibition blocks growth of RB1-positive triple negative breast cancer","volume":"11","author":"Wu","year":"2020","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.cbi.2026.112084_bib122","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11010033","article-title":"Ovarian cancer relies on glucose transporter 1 to fuel glycolysis and growth: anti-tumor activity of BAY-876","volume":"11","author":"Ma","year":"2018","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.cbi.2026.112084_bib123","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1042\/BJ20080622","article-title":"Interaction of tryptophan derivatives with SLC6A14 (ATB0,+) reveals the potential of the transporter as a drug target for cancer chemotherapy","volume":"414","author":"Karunakaran","year":"2008","journal-title":"Biochem. J."},{"issue":"1","key":"10.1016\/j.cbi.2026.112084_bib124","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/s13046-018-0907-z","article-title":"The LAT1 inhibitor JPH203 reduces growth of thyroid carcinoma in a fully immunocompetent mouse model","volume":"37","author":"H\u00e4fliger","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.cbi.2026.112084_bib125","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1021\/cb500120x","article-title":"Monoterpene glycoside ESK246 from Pittosporum targets LAT3 amino acid transport and prostate cancer cell growth","volume":"9","author":"Wang","year":"2014","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.cbi.2026.112084_bib126","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.bcp.2016.08.010","article-title":"KR-33028, a potent inhibitor of the Na+\/H+ exchanger NHE1, suppresses metastatic potential of triple-negative breast cancer cells","volume":"118","author":"Amith","year":"2016","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"10.1016\/j.cbi.2026.112084_bib127","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s11523-024-01054-z","article-title":"ASCT2-Targeting antibody-drug conjugate MEDI7247 in adult patients with relapsed\/refractory hematological malignancies: a First-in-Human, phase 1 study","volume":"19","author":"Maris","year":"2024","journal-title":"Targeted Oncol."},{"issue":"1","key":"10.1016\/j.cbi.2026.112084_bib128","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s11307-015-0862-4","article-title":"Preclinical evaluation of 4-[18F]Fluoroglutamine PET to assess ASCT2 expression in lung cancer","volume":"18","author":"Hassanein","year":"2016","journal-title":"Mol. Imag. Biol."},{"issue":"11","key":"10.1016\/j.cbi.2026.112084_bib129","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1007\/s00259-010-1523-0","article-title":"Synthesis and biological evaluation of [(18)F]tetrafluoroborate: a PET imaging agent for thyroid disease and reporter gene imaging of the sodium\/iodide symporter","volume":"37","author":"Jauregui-Osoro","year":"2010","journal-title":"Eur. J. Nucl. Med. Mol. Imag."},{"key":"10.1016\/j.cbi.2026.112084_bib130","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107964","article-title":"Amino acid transporter LAT1 (SLC7A5) as a molecular target for cancer diagnosis and therapeutics","volume":"230","author":"Kanai","year":"2022","journal-title":"Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.cbi.2026.112084_bib131","doi-asserted-by":"crossref","first-page":"615","DOI":"10.2967\/jnumed.107.048231","article-title":"Cancer detection using a PET tracer, 11C-glycylsarcosine, targeted to H+\/peptide transporter","volume":"49","author":"Mitsuoka","year":"2008","journal-title":"J. Nucl. Med."},{"issue":"6","key":"10.1016\/j.cbi.2026.112084_bib132","doi-asserted-by":"crossref","first-page":"5253","DOI":"10.1021\/acsnano.7b08499","article-title":"Silencing of intestinal glycoprotein CD98 by orally targeted nanoparticles enhances chemosensitization of Colon cancer","volume":"12","author":"Xiao","year":"2018","journal-title":"ACS Nano"},{"issue":"7938","key":"10.1016\/j.cbi.2026.112084_bib133","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/d41586-022-03767-5","article-title":"Folate transporter offers clues for anticancer drugs","volume":"612","author":"Matherly","year":"2022","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.cbi.2026.112084_bib134","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1021\/acs.jmedchem.7b00049","article-title":"Combination of l-Carnitine with lipophilic linkage-donating gemcitabine derivatives as intestinal novel organic cation transporter 2-Targeting oral prodrugs","volume":"60","author":"Wang","year":"2017","journal-title":"J. Med. Chem."},{"issue":"13","key":"10.1016\/j.cbi.2026.112084_bib135","first-page":"5000","article-title":"Nucleoside transporter profiles in human pancreatic cancer cells: role of hCNT1 in 2',2'-difluorodeoxycytidine- induced cytotoxicity","volume":"9","author":"Garc\u00eda-Manteiga","year":"2003","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.cbi.2026.112084_bib136","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1408746","article-title":"A virus-like-particle immunotherapy targeting epitope-specific anti-xCT expressed on cancer stem cell inhibits the progression of metastatic cancer in vivo","volume":"7","author":"Bolli","year":"2018","journal-title":"OncoImmunology"},{"issue":"1","key":"10.1016\/j.cbi.2026.112084_bib137","article-title":"Amino acid transporter LAT1 is expressed on cancer cell-derived exosomes with potential as a diagnostic and prognostic biomarker","volume":"14","author":"Liu","year":"2024","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.cbi.2026.112084_bib138","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1021\/acsmedchemlett.3c00266","article-title":"Platinum-acridine agents with high activity in cancers expressing the solute carrier MATE1 (SLC47A1)","volume":"14","author":"Zhang","year":"2023","journal-title":"ACS Med. Chem. Lett."},{"issue":"2","key":"10.1016\/j.cbi.2026.112084_bib139","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15020364","article-title":"The role of solute carrier transporters in efficient anticancer drug delivery and therapy","volume":"15","author":"Puris","year":"2023","journal-title":"Pharmaceutics"},{"issue":"5","key":"10.1016\/j.cbi.2026.112084_bib140","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cmet.2016.08.011","article-title":"LDHA-associated lactic acid production blunts tumor immunosurveillance by T and NK cells","volume":"24","author":"Brand","year":"2016","journal-title":"Cell Metab."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279726001924?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279726001924?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T02:06:05Z","timestamp":1778724365000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279726001924"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":140,"alternative-id":["S0009279726001924"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2026.112084","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Solute carrier transporters in tumor metabolism and tumor immunity","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2026.112084","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112084"}}